Print previewpersonal data approved: 2023. IV. 19. Publications |
2022
 from data base, 2023. I. 12. |
Kata Husi, László Imre Pinczés, Zsolt Fejes, Béla Nagy Jr., Árpád Illés, Zsófia Miltényi: Combined prognostic role of TARC and interim 18F-FDG PET/CT in patients with Hodgkin lymphoma-real world observational study, HELLENIC JOURNAL OF NUCLEAR MEDICINE 25: (2) pp. 125-131. type of document: Journal paper/Article language: English
|
2022
 from data base, 2023. I. 12. |
Madarász Kristóf, Mótyán János András, Bedekovics Judit, Miltényi Zsófia, Ujfalusi Anikó, Méhes Gábor, Mokánszki Attila: Deep Molecular and In Silico Protein Analysis of p53 Alteration in Myelodysplastic Neoplasia and Acute Myeloid Leukemia, CELLS 11: (21) p. 3475. type of document: Journal paper/Article language: English URL |
2020
 from data base, 2023. I. 12. |
Pinczés László Imre, Szabó Roxána, Illés Árpád, Földeák Dóra, Piukovics Klára, Szomor Árpád, Gopcsa László, Miltényi Zsófia: Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma, ANNALS OF HEMATOLOGY 99: (10) pp. 2385-2392. type of document: Journal paper/Article number of independent citations: 6 language: English URL |
2019
 from data base, 2023. I. 12. |
Méhes Gábor, Matolay Orsolya, Beke Lívia, Czenke Marianna, Jóna Ádám, Miltényi Zsófia, Illés Árpád, Bedekovics Judit: Hypoxia related carbonic anhydrase IX expression is associated with unfavourable response to first-line therapy in classical Hodgkin's lymphoma, HISTOPATHOLOGY 74: (5) pp. 699-708. type of document: Journal paper/Article number of independent citations: 2 language: English URL |
2018
 from data base, 2023. I. 12. |
L Pinczes, Z Miltenyi, A Illes: Young adults diagnosed with Hodgkin lymphoma are at risk of relapsing late: a comprehensive analysis of late relapse in Hodgkin lymphoma, JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 144: (5) pp. 935-943. type of document: Journal paper/Article number of independent citations: 3 language: English URL |
2017
 from data base, 2023. I. 12. |
Molnár Zsuzsa, Pinczés László Imre, Piukovics Klára, Istenes Ildikó, Wolf Krisztina, Csukly Zoltán, Szomor Árpád, Illés Árpád, Miltényi Zsófia: Relabáló/refrakter Hodgkin-lymphoma brentuximab vedotin kezelése. Hazai tapasztalatok, ORVOSI HETILAP 158: (41) pp. 1630-1634. type of document: Journal paper/Article language: Hungarian URL |
2016
 from data base, 2016. IX. 28. |
L Pinczes, Z Miltenyi, A Jona, F Magyari, K Husi, A Illes: How the Epidemiology of Hodgkin Lymphoma changed in Debrecen, Hungary, Medical Research Archives 4: (6) pp. 1-13. type of document: Journal paper/Article language: English
|
2015
 from data base, 2016. IX. 28. |
Illes A, Jona A, Miltenyi Z: Brentuximab vedotin for treating Hodgkin's lymphoma: an analysis of pharmacology and clinical efficacy., EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 11: (3) pp. 451-459. type of document: Journal paper/Article language: English DOI |
2015
 from data base, 2016. IX. 28. |
Miltenyi Z, Barna S, Garai I, Simon Z, Jona A, Magyari F, Gergely M, Nagy Z, Keresztes K, Pettendi P, Illes A: Prognostic value of interim and restaging PET/CT in Hodgkin lymphoma. Results of the CHEAP (Chemotherapy Effectiveness Assessment by PET/CT) study - long term observation., NEOPLASMA 62: (4) pp. 627-634. type of document: Journal paper/Article number of independent citations: 2 language: English DOI |
2010
 from data base, 2016. IX. 28. |
Molnar Zs, Miltenyi Zs, Keresztes K, Borbenyi Z, Marton I, Deak B, Galuska L, Rosta A, Schneider T, Tron L, Varady E, Simon Zs, Illes A: Prognostic value of FDG-PET in Hodgkin lymphoma for posttreatment evaluation. Long-term follow-up results, NEOPLASMA 57: (4) pp. 349-354. type of document: Journal paper/Article number of independent citations: 6 language: English URL |
| Number of independent citations to these publications: | 19  |
|
|